The company presented new data on the PGx test this week and expressed confidence that they can secure broader payor coverage for it.
The company had total revenues of $193.5 million during the quarter, driven by continued increases in revenue and test volume for its more recently launched and acquired tests.
The CATCH-KB database is a standardized variant repository meant to support new research into prevention of chemotherapy-induced cardiotoxicity.
China has been a key focus for Agena, which established a Shanghai subsidiary in 2015.
The Bosch Institute for Clinical Pharmacology will deliver pharmacogenomic recommendations to physicians and let patients see their test results on the web.
Innovation Institute member-owner Avera Health will use 2bPrecise's cloud-based platform with its GeneFolio medication test.
Meditech, one of the oldest existing EHR companies, has staked out a role in supporting precision medicine with drug-gene interaction testing.
The health system has changed the way it offers patients pharmacogenomics and has mandated a new assessment in annual visits intended to identify patients eligible for other genetic tests.
In Cell this week: effect of genetic variation on response to GPCR-targeting drugs, protein-metabolite interactions in E. coli, and more.
The companies will develop a platform for sample and workflow management, genetic data interpretation, and external client communication.
Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.
A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.
In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.
NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.